SCHEMBL7538441

SCHEMBL7538441

CO[C@H]1O[C@H](COCCOCCO)[C@@H](OCCOCCO)[C@H](OCCOCCO)[C@H]1OCCOCCO

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SSTR1 P30872 1/20 0.47
▸ SSTR2 P30874 1/20 0.47
▸ SSTR4 P31391 1/20 0.47
▸ SSTR3 P32745 1/20 0.47
▸ SSTR5 P35346 1/20 0.47
▸ MEN1 O00255 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ PTPN1 P18031 3/20 0.32
▸ PTPN2 P17706 2/20 0.32
▸ TNF P01375 1/20 0.32
▸ LGALS8 O00214 2/20 0.31
▸ BCHE P06276 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ CDC25B P30305 1/20 0.30
▸ TSHR P16473 1/20 0.30
▸ MAPK1 P28482 1/20 0.30
▸ TACR1 P25103 1/20 0.30
▸ HPSE Q9Y251 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14632200 0.94 SSTR1 (0.49) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL9780103 0.94 SSTR1 (0.49) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL5488121 0.85 SSTR1 (0.53) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL14342168 0.85 SSTR1 (0.53) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL12204432 0.79 LGALS8 (0.35) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL14925558 0.79 LGALS8 (0.40) MEN1KMT2ALGALS8
SCHEMBL14632135 0.78 SSTR4 (0.58) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL14925559 0.78 GJB2 (0.39) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL18297794 0.78 SSTR4 (0.40) SSTR1SSTR2SSTR4SSTR3SSTR5
SCHEMBL7054827 0.78 SSTR1 (0.48) SSTR1SSTR2SSTR4SSTR3SSTR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002032963-A1 IMMUNOADJUVANT SYSTEMS ALCHEMIA PTY LTD (AU) 2002-04-25 — — WO disclosed
Send feedback